De Neers Tools (DENEERS)

Score breakdown: P/E: 3/3 · ROCE: 1/2 · Growth: 1/2 · Dividend: 0/1

Key Financials

Strengths

• Low P/E of 7.01 suggests inexpensive valuation relative to current earnings
• ROCE of 21.94% indicates solid capital efficiency
• Piotroski F-score of 6/9 shows reasonable financial health
• Promoter holding of 47.54% aligns management interests with minority shareholders
• Company remains profitable with latest quarter net profit of ₹9 Cr

Concerns

• Sales growth is negative at -3.48%, signaling cyclical weakness
• Profit growth of 0.23% is nearly stagnant, reflected in high PEG of 30.48
• No dividend yield (0.00%), offering no income cushion
• Stock down over 50% from 52-week high of ₹325, indicating market caution

AI Analysis

When I look at De Neers Tools, I see a classic cyclical value proposition, but also a warning sign. The stock trades at ₹151 with a market cap of just ₹124 Cr, giving a P/E of 7.01 against earnings of roughly ₹17.7 Cr. That is cheap on the surface. But as Graham taught, cheap can be a trap if the business is deteriorating. Sales shrank 3.48% last year, and profit growth is essentially flat at 0.23%. The PEG ratio of 30.48 confirms that this is not a growth story. Still, the company earns a healthy ROCE of 21.94%, which suggests decent capital efficiency despite the cyclical downturn. The Piotroski F-score of 6/9 indicates acceptable financial health, though not stellar. The lack of dividend is disappointing for a small-cap investor seeking income. Promoter holding of 47.54% aligns owners with shareholders, but the stock has fallen from its 52-week high of ₹325 to ₹151, meaning the market has already repriced expectations. In the iron and steel products space, moats are thin; pricing power depends on commodity cycles and input costs. The latest quarter shows sales of ₹67 Cr and net profit of ₹9 Cr, so the business is still profitable. But I need to see revenue stabilize before I get excited. At this price, the margin of safety exists only if the cycle turns upward and sales growth returns. If not, this is a value trap. I would keep it on my watchlist, not buy it blindly. The numbers do not yet speak of a durable competitive advantage. I want consistency, not just a low P/E.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer